img

Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Eye Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) key manufacturers include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. Alkeus Pharmaceuticals, Amgen, Biovista are top 3 players and held % sales share in total in 2022.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) can be divided into Dominant Optic Atrophy and Recessive Optic Atrophy, etc. Dominant Optic Atrophy is the mainstream product in the market, accounting for % sales share globally in 2022.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is widely used in various fields, such as Hospitals, Eye Clinics, Medical Research Institute and Other, etc. Hospitals provides greatest supports to the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) industry development. In 2022, global % sales of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alkeus Pharmaceuticals
Amgen
Biovista
Editas Medicine
GenSight Biologics
Ixchel Pharma
Khondrion
Mitotech
ProQR Therapeutics
Sanofi
Spark Therapeutics
Stealth BioTherapeutics
Usher Syndrome
Segment by Type
Dominant Optic Atrophy
Recessive Optic Atrophy

Segment by Application


Hospitals
Eye Clinics
Medical Research Institute
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) introduction, etc. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Overview
1.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment by Type
1.2.1 Dominant Optic Atrophy
1.2.2 Recessive Optic Atrophy
1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Type (2024-2034)
1.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size Review by Type (2024-2024)
1.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2024-2024)
1.4.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2024-2024)
2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competition by Company
2.1 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2024-2024)
2.2 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2024-2024)
2.3 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (2024-2024)
2.4 Global Top Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation and Trends
2.5.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2022)
2.7 Date of Key Manufacturers Enter into Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
2.8 Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Status and Outlook by Region
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Region
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2024-2024)
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2024-2024)
3.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Region
3.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2024-2034)
3.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2024-2034)
3.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application
4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment by Application
4.1.1 Hospitals
4.1.2 Eye Clinics
4.1.3 Medical Research Institute
4.1.4 Other
4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Application (2024-2034)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size Review by Application (2024-2024)
4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2024-2024)
4.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2024-2024)
5 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
5.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Country
5.1.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2024)
5.1.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2024)
5.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Country
5.2.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2034)
5.2.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2034)
6 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
6.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Country
6.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2024)
6.1.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2024)
6.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Country
6.2.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2034)
6.2.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2034)
7 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region
7.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Region
7.1.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Region
7.2.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2024-2034)
8 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
8.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Country
8.1.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2024)
8.1.3 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2024)
8.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Country
8.2.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2034)
9 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Country
9.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Country
9.1.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Country
9.2.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alkeus Pharmaceuticals
10.1.1 Alkeus Pharmaceuticals Company Information
10.1.2 Alkeus Pharmaceuticals Introduction and Business Overview
10.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.1.5 Alkeus Pharmaceuticals Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.2.5 Amgen Recent Development
10.3 Biovista
10.3.1 Biovista Company Information
10.3.2 Biovista Introduction and Business Overview
10.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.3.5 Biovista Recent Development
10.4 Editas Medicine
10.4.1 Editas Medicine Company Information
10.4.2 Editas Medicine Introduction and Business Overview
10.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.4.5 Editas Medicine Recent Development
10.5 GenSight Biologics
10.5.1 GenSight Biologics Company Information
10.5.2 GenSight Biologics Introduction and Business Overview
10.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.5.5 GenSight Biologics Recent Development
10.6 Ixchel Pharma
10.6.1 Ixchel Pharma Company Information
10.6.2 Ixchel Pharma Introduction and Business Overview
10.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.6.5 Ixchel Pharma Recent Development
10.7 Khondrion
10.7.1 Khondrion Company Information
10.7.2 Khondrion Introduction and Business Overview
10.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.7.5 Khondrion Recent Development
10.8 Mitotech
10.8.1 Mitotech Company Information
10.8.2 Mitotech Introduction and Business Overview
10.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.8.5 Mitotech Recent Development
10.9 ProQR Therapeutics
10.9.1 ProQR Therapeutics Company Information
10.9.2 ProQR Therapeutics Introduction and Business Overview
10.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.9.5 ProQR Therapeutics Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.10.5 Sanofi Recent Development
10.11 Spark Therapeutics
10.11.1 Spark Therapeutics Company Information
10.11.2 Spark Therapeutics Introduction and Business Overview
10.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.11.5 Spark Therapeutics Recent Development
10.12 Stealth BioTherapeutics
10.12.1 Stealth BioTherapeutics Company Information
10.12.2 Stealth BioTherapeutics Introduction and Business Overview
10.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.12.5 Stealth BioTherapeutics Recent Development
10.13 Usher Syndrome
10.13.1 Usher Syndrome Company Information
10.13.2 Usher Syndrome Introduction and Business Overview
10.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
10.13.5 Usher Syndrome Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industrial Chain Analysis
11.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
11.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
11.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
11.4.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
11.4.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
12.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Dominant Optic Atrophy
Table 2. Major Company of Recessive Optic Atrophy
Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (K Pcs)
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US& Million)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share in Value by Type (2024-2024)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2024-2024) & (USD/Piece)
Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type (2024-2034)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2024-2034) & (USD/Piece)
Table 14. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (K Pcs)
Table 15. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2024)
Table 17. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2024)
Table 19. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2024)
Table 21. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2024)
Table 23. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company (2024-2024) & (K Pcs)
Table 25. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Company (2024-2024)
Table 26. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Company (2024-2024)
Table 28. Global Market Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Company (2024-2024) & (USD/Piece)
Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2022)
Table 32. Date of Key Manufacturers Enter into Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
Table 33. Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (K Pcs)
Table 37. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2024-2024)
Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2024-2034)
Table 45. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2034)
Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (K Pcs)
Table 48. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2024-2024)
Table 51. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2024-2024) & (USD/Piece)
Table 52. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2024-2034)
Table 56. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2024-2034) & (USD/Piece)
Table 57. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) (K Pcs)
Table 58. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) (K Pcs)
Table 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) (K Pcs)
Table 62. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) (K Pcs)
Table 64. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) (K Pcs)
Table 66. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 68. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2024)
Table 71. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 76. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (K Pcs)
Table 84. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 92. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 100. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Country (2024-2034)
Table 107. Alkeus Pharmaceuticals Company Information
Table 108. Alkeus Pharmaceuticals Introduction and Business Overview
Table 109. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 110. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 111. Alkeus Pharmaceuticals Recent Development
Table 112. Amgen Company Information
Table 113. Amgen Introduction and Business Overview
Table 114. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 115. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 116. Amgen Recent Development
Table 117. Biovista Company Information
Table 118. Biovista Introduction and Business Overview
Table 119. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 120. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 121. Biovista Recent Development
Table 122. Editas Medicine Company Information
Table 123. Editas Medicine Introduction and Business Overview
Table 124. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 125. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 126. Editas Medicine Recent Development
Table 127. GenSight Biologics Company Information
Table 128. GenSight Biologics Introduction and Business Overview
Table 129. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 130. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 131. GenSight Biologics Recent Development
Table 132. Ixchel Pharma Company Information
Table 133. Ixchel Pharma Introduction and Business Overview
Table 134. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 135. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 136. Ixchel Pharma Recent Development
Table 137. Khondrion Company Information
Table 138. Khondrion Introduction and Business Overview
Table 139. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 140. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 141. Khondrion Recent Development
Table 142. Mitotech Company Information
Table 143. Mitotech Introduction and Business Overview
Table 144. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 145. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 146. Mitotech Recent Development
Table 147. ProQR Therapeutics Company Information
Table 148. ProQR Therapeutics Introduction and Business Overview
Table 149. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 150. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 151. ProQR Therapeutics Recent Development
Table 152. Sanofi Company Information
Table 153. Sanofi Introduction and Business Overview
Table 154. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 155. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 156. Sanofi Recent Development
Table 157. Spark Therapeutics Company Information
Table 158. Spark Therapeutics Introduction and Business Overview
Table 159. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 160. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 161. Spark Therapeutics Recent Development
Table 162. Stealth BioTherapeutics Company Information
Table 163. Stealth BioTherapeutics Introduction and Business Overview
Table 164. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 165. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 166. Stealth BioTherapeutics Recent Development
Table 167. Usher Syndrome Company Information
Table 168. Usher Syndrome Introduction and Business Overview
Table 169. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2024-2024)
Table 170. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 171. Usher Syndrome Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 175. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
Table 176. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
Table 177. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 178. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 179. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Picture
Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Status and Outlook (2024-2034) & (K Pcs)
Figure 5. Product Picture of Dominant Optic Atrophy
Figure 6. Global Dominant Optic Atrophy Sales YoY Growth (2024-2034) & (K Pcs)
Figure 7. Product Picture of Recessive Optic Atrophy
Figure 8. Global Recessive Optic Atrophy Sales YoY Growth (2024-2034) & (K Pcs)
Figure 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type in 2022 & 2034
Figure 11. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2022
Figure 12. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2022
Figure 13. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2022
Figure 14. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2022
Figure 17. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2022
Figure 23. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2024-2034) & (K Pcs)
Figure 26. Product Picture of Eye Clinics
Figure 27. Global Eye Clinics Sales YoY Growth (2024-2034) & (K Pcs)
Figure 28. Product Picture of Medical Research Institute
Figure 29. Global Medical Research Institute Sales YoY Growth (2024-2034) & (K Pcs)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (K Pcs)
Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application in 2022 & 2034
Figure 34. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2022
Figure 35. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2022
Figure 36. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2022
Figure 37. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2022
Figure 40. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Cost Structure
Figure 45. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries